Download Medtech 2015 in Review, this report from our editorial team EP Vantage, shows that total value of mergers and acquisitions in the medtech sector in 2015 reached an unprecedented high; a figure that held true even if the record breaking acquisition of Covidien by Medtronic was excluded.
The report offers analysis and expert commentary on M&A deals, venture financing, initial public offerings and FDA approvals in the medtech sector in 2015.
Total M&A value in 2015 in the medtech sector reached an unprecedented high
Questions remain about how the medtech sector can stimulate investing and deals for emerging to mid-size companies, to support sector innovation and growth
A total of 51 novel medical devices were approved by the FDA in 2015, the most in a decade
